Showing results (31-40 of 564) with videos related to
Sort By:
Pageof 57
Translational Oncology|April 17, 2025
LUNAR: Full Moon or Eclipse? An exploration into tumor treating fields in lung cancerTimothée Olivier, Vinay PrasadThe Yale Journal of Biology and Medicine|December 20, 2011
Medical reversal: why we must raise the bar before adopting new technologiesVinay Prasad, Adam CifuTranslational Oncology|October 23, 2021
Sacituzumab govitecan in metastatic triple negative breast cancer (TNBC): Four design features in the ASCENT trial potentially favored the experimental armTimothee Olivier, Vinay PrasadCardiovascular Drugs and Therapy|October 3, 2018
Correction to: Do Limitations in the Design of PARADIGM-HF Justify the Slow Real World Uptake of Sacubitril/Valsartan (Entresto)?Rosa Ahn, Vinay PrasadTranslational Oncology|April 1, 2022
Tebentafusp in first-line melanoma trials: An outperforming outlierTimothée Olivier, Vinay PrasadDigital Health|August 25, 2022
Characteristics of Facebook's third-party medical fact checkersAlyson Haslam, Vinay PrasadJournal of the American Geriatrics Society|September 23, 2025
Age of Patients in Trials Submitted to the FDA Versus Age in Average Patients With CancerAlyson Haslam, Vinay PrasadOpen Forum Infectious Diseases|September 17, 2024
A Systematic Review of Nirmatrelvir/Ritonavir and Molnupiravir for the Treatment of Coronavirus Disease 2019Alyson Haslam, Vinay PrasadEuropean Urology Focus|April 7, 2021
Old-fashioned Intelligence Will Always Be Needed in MedicineKerrington Powell, Vinay PrasadTranslational Oncology|February 23, 2022
The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDATimothée Olivier, Vinay PrasadPageof 57